Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Other Non-Current Liabilities: 2009-2024

Historic Other Non-Current Liabilities for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $181.9 million.

  • UNITED THERAPEUTICS's Other Non-Current Liabilities rose 44.22% to $214.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $214.6 million, marking a year-over-year increase of 44.22%. This contributed to the annual value of $181.9 million for FY2024, which is 133.80% up from last year.
  • Per UNITED THERAPEUTICS's latest filing, its Other Non-Current Liabilities stood at $181.9 million for FY2024, which was up 133.80% from $77.8 million recorded in FY2023.
  • UNITED THERAPEUTICS's 5-year Other Non-Current Liabilities high stood at $181.9 million for FY2024, and its period low was $77.8 million during FY2023.
  • Its 3-year average for Other Non-Current Liabilities is $121.4 million, with a median of $104.6 million in 2022.
  • As far as peak fluctuations go, UNITED THERAPEUTICS's Other Non-Current Liabilities dropped by 25.62% in 2023, and later surged by 133.80% in 2024.
  • Over the past 5 years, UNITED THERAPEUTICS's Other Non-Current Liabilities (MRY) stood at $96.5 million in 2020, then increased by 8.60% to $104.8 million in 2021, then decreased by 0.19% to $104.6 million in 2022, then decreased by 25.62% to $77.8 million in 2023, then soared by 133.80% to $181.9 million in 2024.
  • Its Other Non-Current Liabilities stands at $181.9 million for FY2024, versus $77.8 million for FY2023 and $104.6 million for FY2022.